Products and Services
-
Device developer Iconovo has received an order worth up to 4.9 million Swedish kronor from Immune System Regulation (ISR) for an intranasal version of Iconovo’s ICOone single dose DPI, the company said. In March 2021,… Read more . . .
-
Philip Morris International (PMI) has announced an offer of ~£1.05 billion for the acquisition of inhalation CDMO Vectura. In May 2021, Vectura announced that it would be acquired by the Carlyle Group for £958 million.… Read more . . .
-
Inhalation Sciences (ISAB) announced that its CRO division, Inhalation Research Services (IRS), has signed an agreement with “an innovative US pharma company that is developing novel mRNA therapies for the treatment of cystic fibrosis and other… Read more . . .
-
Copley Scientific announced that it has joined the Industries Forum of the UK’s Taskforce for Lung Health, and Copley personnel will share their expertise to help advance the taskforce’s five-year plan “to improve the nation’s lung… Read more . . .
-
Inhalation CDMO Vectura has announced an agreement to provide preclinical development services for Incannex Healthcare’s IHL-216A CBD/isoflurane, which Incannex is developing for the treatment of traumatic brain injury. In addition to performing screening, stability, and optimization… Read more . . .
-
Inhaler monitoring company Adherium has submitted a 510(k) application for a new Hailie sensor designed to work with the Symbicort MDI the company announced. The company recently rejected a takeover bid from another Australian asthma… Read more . . .
-
Noveome Biotherapeutics has signed a commercial license agreement for the use of SipNose’s intranasal Cribriform Targeted Device (CT6) for delivery of its ST266 secretome for the treatment of ophthalmological and CNS conditions the companies said.… Read more . . .
-
The Swedish Medical Product Agency (Läkemedelsverket) has approved an application from Inhalation Sciences (ISAB) for a clinical trial of its PreciseInhale aerosol generation system, the company said. ISAB expects to initiate the trial in June… Read more . . .
-
A newly formed company called Murano Bidco, which is controlled by the Carlyle Group, has agreed to pay approximately £958 million to acquire inhalation CDMO Vectura, the companies have announced. According to the announcement, Bidco… Read more . . .
-
Aerosol research instrument company Inhalation Sciences (ISAB) has announced the formation of a new scientific advisory board, which will begin meeting on June 1, 2021 to discuss how the company’s PreciseInhale laboratory aerosol dosing system can be… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden